These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22414679)

  • 1. Synthesis and structure elucidation of novel fused 1,2,4-triazine derivatives as potent inhibitors targeting CYP1A1 activity.
    El Massry AM; Asal AM; Khattab SN; Haiba NS; Awney HA; Helmy M; Langer V; Amer A
    Bioorg Med Chem; 2012 Apr; 20(8):2624-37. PubMed ID: 22414679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cu-mediated N-arylation of 1,2,3-triazin-4-ones: synthesis of fused triazinone derivatives as potential inhibitors of chorismate mutase.
    Shiva Kumar K; Adepu R; Sandra S; Rambabu D; Rama Krishna G; Malla Reddy C; Misra P; Pal M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1146-50. PubMed ID: 22189133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
    Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives.
    Hou S; Xu H; Hu J; Hou J; Wang Y; Jin Z; Wan DCC; Hu C
    Med Chem; 2018; 14(1):67-73. PubMed ID: 28969571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
    Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
    Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
    Bera H; Lee MH; Sun L; Dolzhenko AV; Chui WK
    Bioorg Chem; 2013 Oct; 50():34-40. PubMed ID: 23968897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
    Bekircan O; Küxük M; Kahveci B; Kolayli S
    Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere.
    Raboisson P; Schultz D; Muller C; Reimund JM; Pinna G; Mathieu R; Bernard P; Do QT; Desjarlais RL; Justiano H; Lugnier C; Bourguignon JJ
    Eur J Med Chem; 2008 Apr; 43(4):816-29. PubMed ID: 17640774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
    Borzilleri RM; Cai ZW; Ellis C; Fargnoli J; Fura A; Gerhardt T; Goyal B; Hunt JT; Mortillo S; Qian L; Tokarski J; Vyas V; Wautlet B; Zheng X; Bhide RS
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1429-33. PubMed ID: 15713401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
    Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
    Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
    Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity.
    Dao P; Jarray R; Le Coq J; Lietha D; Loukaci A; Lepelletier Y; Hadj-Slimane R; Garbay C; Raynaud F; Chen H
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4552-6. PubMed ID: 23845217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines.
    Ma X; Tan ST; Khoo CL; Sim HM; Chan LW; Chui WK
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5428-31. PubMed ID: 21788136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF NEW FUSED TRIAZINE DERIVATIVES BASED ON 6-METHYL-3-THIOXO-1,2,4-TRIAZIN-5-ONE.
    Abd El-All AS; Hassan AS; Osman SA; Yosef HA; Abdel-Hady WH; El-Hashash MA; Atta-Allah SR; Ali MM; El Rashedy AA
    Acta Pol Pharm; 2016; 73(1):79-92. PubMed ID: 27008803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial evaluation of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
    Almajan GL; Barbuceanu SF; Bancescu G; Saramet I; Saramet G; Draghici C
    Eur J Med Chem; 2010 Dec; 45(12):6139-46. PubMed ID: 21036422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
    Wrobleski ST; Lin S; Hynes J; Wu H; Pitt S; Shen DR; Zhang R; Gillooly KM; Shuster DJ; McIntyre KW; Doweyko AM; Kish KF; Tredup JA; Duke GJ; Sack JS; McKinnon M; Dodd J; Barrish JC; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2739-44. PubMed ID: 18364256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.
    Sun L; Bera H; Chui WK
    Eur J Med Chem; 2013 Jul; 65():1-11. PubMed ID: 23688695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors.
    Bera H; Dolzhenko AV; Sun L; Dutta Gupta S; Chui WK
    Chem Biol Drug Des; 2013 Sep; 82(3):351-60. PubMed ID: 23758794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two regioisomers of condensed thioheterocyclic triazine synthesized from 6-phenyl-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-5-one.
    Hori A; Ishida Y; Kikuchi T; Miyamoto K; Sakaguchi H
    Acta Crystallogr C; 2009 Dec; 65(Pt 12):o593-7. PubMed ID: 19966438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.